Effects of daytime ASV therapy on heart failure
Not Applicable
Recruiting
- Conditions
- chronic heart failure
- Registration Number
- JPRN-UMIN000011769
- Lead Sponsor
- Department of Cardiovascular and Medicine, Akita University Graduate School of Medicine,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients undergoing positive airway pressure 2) patients undergoing hemodialysis 3) chronic and acute inflammation disease or malignant disease 4) phyaryngial disease 5) patients who could not have conventional medical therapy 6) uncontrolled diabetes and hypertension 7) hepatitis, liver cirrhosis, liver cancer, joundice 8) acute coronary syndrome 9) patients who will have heart surgery 10) pregnant 11) patients who will have pacing therapy 12) patients who have serious cerebrovascular disease 13) patients who have intravenous administration for heart failure 14) chronic renal failure (Cre>=3.0) 15) serious respiratory disease 16) subjects whose doctor in charge do not agree to join the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular events
- Secondary Outcome Measures
Name Time Method Plasma norepinephrine, serum creatinine, microalbuminurea, eGFR, hs-CRP, Hb, BGA, LVEF, Dd, Ds, LVEDV, LVESV, E/A, E/e', LA volume, BNP, administration changes due to HF worsening, polysomnography, respiratory function data